InterventionsHuman trial
Oral Semaglutide and Cardiovascular Outcomes by Baseline A1C and BMI in People with Type 2 Diabetes in the SOUL Trial
ADA Scientific Sessions 2025 Abstract
The paper
Silvio E. Inzucchi, Rohana Abdul Ghani, John Eric Deanfield, John B. Buse
Show 17 more authors
Mads D.M. Engelmann, G. Kees Hovingh, Ole Kleist Jeppesen, Monika Kellerer, Kabirdev Mandavya, Johannes F. Mann, Nikolaus Marx, Chantal Mathieu, Darren K. McGuire, Viswanathan Mohan, Sharon L. Mulvagh, Rodica Pop‐Busui, Neil R Poulter, Maria Sejersten Ripa, Gabriela Román, Róbinson Sánchez García, Michael Shechter,New Haven
ADA Scientific Sessions 2025 Abstract · 23 Jun 2025
Presented at ADA Scientific Sessions 2025 · Oral 292-OR
